Physician profile
Bashar Safar
NPI 1932386422
$26,358.24
in general payments reported to CMS, 2019-2025
17 companies · $20.78 in 2025
The $20.78 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $801 · 2021: $1,715 · 2022: $391 · 2023: $647 · 2024: $286 · 2025: $20.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $953.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $16,924.61 | 2019-2020 | |
| Ethicon US, LLC | $5,564.12 | 2019-2022 | |
| Medtronic, INC. | $1,573.15 | 2021-2025 | Signia |
| Integra Lifesciences Corporation | $403.59 | 2023-2024 | Integra, Surgimend, Omnigraft |
| Stryker Corporation | $315.73 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $292.96 | 2019-2022 | |
| Intuitive Surgical, INC. | $269.83 | 2019-2024 | Da Vinci Surgical System |
| Davol INC. | $206.91 | 2023 | Phasix Mesh |
| Merck Sharp & Dohme LLC | $182.35 | 2019-2024 | Bridion |
| Covidien LP | $156.72 | 2019 | |
| Allergan, INC. | $133.09 | 2019 | |
| Ambu INC. | $117.58 | 2023 | |
| Olympus America INC. | $97.72 | 2019 | |
| Tela Bio, INC. | $36.74 | 2024 | Ovitex 2s |
| Braintree Laboratories, INC. | $33.24 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $25.63 | 2024 | Solesta |
| Thd America, INC. | $24.27 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bashar Safar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.